Access to therapy via videoconferencing a major advance in OCD treatment
UF Health Apr 08, 2017
Patients with obsessive–compulsive disorder are benefiting from the increasingly widespread availability of therapy through videoconferencing and other computer–based programs, according to a review led by a University of Florida researcher and published in JAMA journal.
The review of randomized controlled trials and meta–analyses led by Carol A. Mathews, MD, the Brooke Professor in the UF College of MedicineÂs department of psychiatry, found that the No. 1 treatment for OCD is cognitive–behavioral therapy, a form of psychotherapy that is goal–oriented and focuses on solutions. The option of participating in face–to–face therapy via the internet – in cases where in–person therapy is not an option due to location or other reason – is considered a major advancement in the treatment of OCD, the review states.
ÂIn lots and lots of places, there is no access to clinicians who specialize in OCD, said Mathews, who is with the Evelyn F. and William L. McKnight Brain Institute of the University of Florida. ÂIf you can access a clinician through Skype or the telephone or a blog, itÂs a major advance because it potentially increases access to care dramatically.Â
The new review also found that medication management can be effective as an enhancement to therapy or on its own if cognitive–behavioral treatment is not available, but Mathews emphasized that therapy remains the gold standard of treatment for OCD. Medications that have been shown to be most effective for treating OCD are selective serotonin reuptake inhibitors, same as the most commonly prescribed antidepressants.
In treatment–resistant cases of OCD, deep brain stimulation surgery has resulted in significant improvement in symptoms, Mathews said. Now approved by the Food and Drug Administration for this use, deep brain stimulation for treatment–resistant OCD is offered by UF Health.
ÂOCD is really underdiagnosed and underrecognized, and we really want to get family practice doctors, pediatricians and internists to start screening for it, Mathews said. ÂOnce itÂs recognized, it can be very effectively treated. If not caught and treated early, this condition can have a profound impact on peopleÂs lives.Â
Mathews said she would like to see a decrease in the average time it takes to diagnose OCD and begin treatment, currently about 10 years.
Next for this line of research, Mathews said, is continuing to work on improving outcomes, particularly for people who are not responding to standard treatments.
Go to Original
The review of randomized controlled trials and meta–analyses led by Carol A. Mathews, MD, the Brooke Professor in the UF College of MedicineÂs department of psychiatry, found that the No. 1 treatment for OCD is cognitive–behavioral therapy, a form of psychotherapy that is goal–oriented and focuses on solutions. The option of participating in face–to–face therapy via the internet – in cases where in–person therapy is not an option due to location or other reason – is considered a major advancement in the treatment of OCD, the review states.
ÂIn lots and lots of places, there is no access to clinicians who specialize in OCD, said Mathews, who is with the Evelyn F. and William L. McKnight Brain Institute of the University of Florida. ÂIf you can access a clinician through Skype or the telephone or a blog, itÂs a major advance because it potentially increases access to care dramatically.Â
The new review also found that medication management can be effective as an enhancement to therapy or on its own if cognitive–behavioral treatment is not available, but Mathews emphasized that therapy remains the gold standard of treatment for OCD. Medications that have been shown to be most effective for treating OCD are selective serotonin reuptake inhibitors, same as the most commonly prescribed antidepressants.
In treatment–resistant cases of OCD, deep brain stimulation surgery has resulted in significant improvement in symptoms, Mathews said. Now approved by the Food and Drug Administration for this use, deep brain stimulation for treatment–resistant OCD is offered by UF Health.
ÂOCD is really underdiagnosed and underrecognized, and we really want to get family practice doctors, pediatricians and internists to start screening for it, Mathews said. ÂOnce itÂs recognized, it can be very effectively treated. If not caught and treated early, this condition can have a profound impact on peopleÂs lives.Â
Mathews said she would like to see a decrease in the average time it takes to diagnose OCD and begin treatment, currently about 10 years.
Next for this line of research, Mathews said, is continuing to work on improving outcomes, particularly for people who are not responding to standard treatments.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries